Filing Details

Accession Number:
0001079974-15-000251
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-04-09 18:02:37
Reporting Period:
2014-04-18
Filing Date:
2015-04-09
Accepted Time:
2015-04-09 18:02:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1389870 Omni Bio Pharmaceutical Inc. OMBP Biological Products, (No Disgnostic Substances) (2836) 208097969
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1377756 Boco Investments Llc 262 East Mountain Ave.
Fort Collins CO 80524
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Acquisiton 2015-02-27 2,998,678 $0.25 10,132,678 No 4 P Direct
Common Acquisiton 2015-02-27 3,000,000 $0.01 13,132,678 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrant Disposition 2014-04-18 2,900,000 $0.00 2,900,000 $0.25
Common Stock Warrant Disposition 2014-04-18 1,450,000 $0.00 1,450,000 $0.25
Common Stock Warrant Acquisiton 2014-04-18 2,900,000 $0.00 2,900,000 $0.25
Common Stock Warrant Acquisiton 2014-04-18 1,450,000 $0.00 1,450,000 $0.25
Common Stock Warrant Acquisiton 2014-04-18 3,000,000 $0.00 3,000,000 $0.01
Common Stock Convertible Note Disposition 2015-02-27 2,400,000 $0.25 2,998,678 $0.25
Common Stock Warrant Disposition 2015-02-27 3,000,000 $0.01 3,000,000 $0.01
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
7,350,000 2009-03-31 2017-03-31 No 4 J Direct
7,350,000 2009-03-31 2017-03-31 No 4 J Direct
7,350,000 2009-03-31 2019-12-31 No 4 J Direct
7,350,000 2009-03-31 2019-12-31 No 4 J Direct
10,350,000 2014-04-18 2015-04-15 No 4 P Direct
7,950,000 2012-10-31 2015-10-31 No 4 C Direct
4,950,000 2014-04-18 2015-04-15 No 4 X Direct
Footnotes
  1. This Warrant amends and restates in its entirety a previous Warrant for the same number of shares for the purpose extending the contractual period to December 31, 2019 and resetting of the Exercise Price to $0.25.
  2. Conversion of the previously reported $600,000 Convertible Promissory Note with principal of $600,000 and accrued interest of $149,669.58.
  3. Exercise of the previously reported 3,000,000 warrants.